All In Biotech

Free tool

FAERS Monitor: Unituxin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125516 or its brand name (Unituxin, Dinutuximab). Reports on generic versions are filed under their own applications.

Reports

859

Serious

757

88% of reports

Hospitalization

300

Death reported

173

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pyrexia172
  • off label use116
  • pain90
  • neuroblastoma recurrent89
  • abdominal pain80
  • vomiting68
  • aspartate aminotransferase increased64
  • alanine aminotransferase increased62
  • hypotension59
  • anaemia58
  • neuroblastoma56
  • hypoalbuminaemia55
  • nausea52
  • pain in extremity51
  • diarrhoea50

Reports by year received

View as table
YearReports
201510
201624
201762
201882
201962
202072
2021138
2022106
2023102
202468
202561
202672

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,300 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neuroblastoma recurrentSignal8919134.314620.5945,531
neuroblastomaSignal564197.33186.7197,021
hypoalbuminaemiaSignal55174.5135.09,255
aspartate aminotransferase increasedSignal6429.523.31,739
alanine aminotransferase increasedSignal6224.819.51,392
pyrexiaSignal17212.210.71,782
abdominal painSignal808.46.8522
anaemiaSignal587.45.8320
hypotensionSignal597.25.6312
pain in extremitySignal514.23.2125
painSignal903.63.0170
vomitingSignal683.52.8124
off label useSignal1163.22.7186
diarrhoea501.91.421
nausea521.61.212

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.